Happy Holidays from the OBI
What a year 2020 has been! We have been through a lot together, and we at the OBI are celebrating the holiday season and the end of a most unusual year. Look for a 2020 OBI recap in next month’s newsletter. Happy Holidays to you and yours!
2021 is almost here. Stay healthy and safe and we hope to see you in person in the new year!
OBI Client Company Wins
SUTUREGARD Medical has some great recent wins:
- Highest revenue month achieved in October 2020, extending our runway
- Completed Clinical Evaluation Reports for CE mark submission, applications for SUTUREGARD ISR and HEMIGARD devices will be filed this month to Notified Body in Germany for CE mark approval
- Official approval as vendor for in hospital sales at Moffitt Cancer Center in Tampa, Florida – national leader in melanoma treatment and research
- Expanded clinical use by podiatry, dermatology, surgical oncology, cardiovascular surgery
- First sales in Australia
Veana Therapeutics, Inc. Founder and CEO, Emmanuel Akporiaye, Ph.D won the Judges’ Award at the Oregon Bio Digital 2020 Conference held from November 17 -19.
Caregiven is on a roll! Their wins include:
- The humbleness and excitement that came with two new investments from extraordinary women
- Seeing our expaning team coalesce as we refine our business model together (special thanks to CareFactor for providing access to Strategyzer)
- Receiving feedback from The Wave Pitch Showcase judges (Canaan, GingerBread Capital, Outlines Venture Group) that “with the right business model, nothing will stop you!”
- Since the end of October, we have been inviting 25 new beta testers each week onto the Caregiven platform
- We’ve received two new investments and have raised $150,000 on our convertible note
- Support me (Candice Smith, Founder & CEO) as I speak at the DIGIN Conference 2020 on the topic of “Evolving the Home Health and Insurance Paradigm in a Post-Pandemic World.”
Inherent Targeting won the Judges’ and People’s Choice awards at the early-stage startup pitch contest at Oregon Bio Digital Conference. Additionally, Inherent Targeting has been invited to present at the McKinsey & Co. Early Stage Investor Conference taking place Monday, December 7th.
Aronora announces clinical data to be presented at the 62nd American Society of Hematology Annual Meeting. For more information, see the December 2, 2020 Newswire press release.
Promedix has had 3 large wins that have accelerated clinical adoption and validation:
- We have an ongoing clinical trial in the ICU and launching a trial in the ED to study our technology’s ability to both improve detection and monitoring of sepsis
- We had an abstract accepted and presented at the American Heart Association National Conference on our technology and patient data
- We had a manuscript accepted in a peer-reviewed journal
Keep the wins coming. We love to celebrate your successes!
Program Recordings on Demand
Great news! You now have the ability to view all of our Lunch and Learns from October, 2019 to the most recent program. These closed caption-enabled videos are available on our website and on our YouTube channel. Subscribe to the Oregon Bioscience Incubator YouTube channel to be notified when new videos are posted, approximately once per month.
Welcome to Our Newest Client Company
Izon Science is the world leading manufacturer of nano-biological separation and characterization tools. Its TRPS measurement system is the most accurate, standardizable and practical method of measuring complex nano-bio particles, while its qEV platform has rapidly become the gold standard in extracellular vesicle separation.
Izon Science joined the OBI on December 1. Welcome, Izon!
Mentor of the Month:
Michael McGarry
Michael McGarry is one of our helpful and engaging mentors in our current Mentoring Program cohort. He is the Founder and President of Forvida, a customer-focused consulting firm passionate about developing health solutions that engage individuals and make health and every day event. Before founding Forvida, Michael had more than 20 years experience in the health care industry, developing innovative programs and medical devices from prototype through FDA approval within small start-up organizations as well as Fortune 500 medical companies.
Michael has been very supportive of the OBI and the larger health sciences ecosystem through his mentoring with OBI, assistance with last spring’s MIT COVID-19 Challenge, the OHSU Invent-a-Thon, and more recently as the presenter for an OBI Virtual Lunch and Learn.
Thank you, Michael, for all you to do to support the community!
Congratulations to Pitch Winners at Oregon Bio’s Digital Conference 2020
Two of OBI’s client companies were winners in the Oregon Bioscience Association’s Digital Conference 2020 pitch event:
- Connor Barth, PhD from Inherent Targeting won the Judges’ award and People’s Choice award for the Early-Stage Startup category
- Emmanuel Akporiaye, PhD from Veana Therapeutics won the Judges’ award for the Later-Stage Startup category
Ken Bates, PhD from Bates Medical Systems and Jeff King, PhD from Virogenomics Bio Development also pitched in this fantastic event.
Congratulations to all – you did a great job!
Events
OBI EVENTS
Virtual Lunch & Learn: The 7 Habits of Highly Effective People in R&D
December 9, 2020
12:00-1:00 PM
Register Now – It’s Almost Full!
COMMUNITY & PARTNER EVENTS
University Lab Partners Presents:
Getting Your Tech Out of the Lab and Onto the Market
December 10, 2020
12:00-1:00 PM
Register Here
PDXWIT Event: From Vision to Game Plan
December 10, 2020
12:00-1:00 PM
Registration Page
TAO CEO Leadership Exchange:
Strengthening Oregon’s Innovation Economy
December 15, 2020
4:00-5:15 PM
Details Here
PDXWIT: Annual Celebration + Awards Ceremony
December 15, 2020
5:00-6:15 PM
Register Here
Oregon Bio’s Holly Jolly Finale
December 17, 2020
4:00-5:30 PM
Happy Hour Registration Page